102nd Day Of Lockdown

Maharashtra1929901046878376 Tamil Nadu102721583781385 Delhi92175630072864 Gujarat34686249411905 Uttar Pradesh2579717597749 West Bengal2048813571717 Telangana2046210195283 Karnataka197108807293 Rajasthan1925615352443 Andhra Pradesh169347632206 Haryana1550911019251 Madhya Pradesh1410610815589 Bihar10911821184 Assam8956583212 Jammu and Kashmir76954856105 Odisha7316535333 Punjab56683989149 Kerala4594243626 Uttarakhand2791190937 Chhatisgarh2339193713 Jharkhand2339160512 Tripura140110931 Manipur13166390 Goa11984783 Himachal Pradesh9796179 Puducherry73930112 Nagaland5351820 Chandigarh4463676 Arunachal Pradesh182601 Mizoram1601230 Sikkim101520 Meghalaya50421
World Neighbours 29 Jun 2020 COVID-19 vaccine can ...

COVID-19 vaccine candidate approved for military use in China

REUTERS
Published Jun 29, 2020, 12:21 pm IST
Updated Jun 29, 2020, 12:21 pm IST
Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials
Representational Image. (AFP)
 Representational Image. (AFP)

Beijing: China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics (6185.HK) after clinical trials proved it was safe and somewhat efficient, the company said on Monday.

The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada.

 

China’s Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing. The vaccine candidate was developed jointly by CanSino and the Beijing Institute of Biotechnology in the Academy of Military Medical Sciences.

“The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department,” CanSino said, referring to the Central Military Commission department where the military use of the vaccine was approved.

The Phase 1 and Phase 2 clinical trials showed the vaccine candidate has potential to prevent diseases caused by the coronavirus, which has killed half a million people globally, but its commercial success cannot be guaranteed, the company said.

No vaccine has yet been approved for commercial use against the illness caused by the new coronavirus, but over a dozen vaccines from more than 100 candidates globally are being tested in humans.

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT